Molecular Partners AG (MOLN)
$3.79-1.56%Close
SELLRECOVERY · day 6
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $142M
- Beta
- 0.69
- P/E (TTM)
- -2.43
- Short % float
- 0.00%
- Days to cover
- 1.0
- SI change
- +13.3%
- 1W
- -3.32%
- 1M
- -9.33%
- vs SPY 1W
- -3.74%
- vs SPY 1M
- -11.39%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on MOLN?
- LOPJLB’s latest quantitative signal on Molecular Partners AG (MOLN) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is MOLN in?
- Molecular Partners AG (MOLN) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Molecular Partners AG (MOLN) do?
- Molecular Partners AG operates as a clinical-stage biopharmaceutical company, specializing in the identification, advancement, and commercialization of innovative therapeutic proteins. The firm's pipeline includes a range of product candidates, many of which utilize its proprietary DARPin® technology. Key developments include Abicipar, a DARPin therapeutic in Phase III clinical trials for addr…